Compare NTRA & CPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTRA | CPRT |
|---|---|---|
| Founded | 2003 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.0B | 32.2B |
| IPO Year | 2015 | 1996 |
| Metric | NTRA | CPRT |
|---|---|---|
| Price | $204.80 | $32.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 5 |
| Target Price | ★ $259.07 | $44.40 |
| AVG Volume (30 Days) | 1.1M | ★ 7.6M |
| Earning Date | 05-07-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.65 | ★ 13.57 |
| EPS | N/A | ★ 0.77 |
| Revenue | $210,939,000.00 | ★ $1,805,695,000.00 |
| Revenue This Year | $18.16 | $1.23 |
| Revenue Next Year | $20.00 | $4.68 |
| P/E Ratio | ★ N/A | $43.38 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $130.29 | $32.20 |
| 52 Week High | $256.36 | $63.77 |
| Indicator | NTRA | CPRT |
|---|---|---|
| Relative Strength Index (RSI) | 53.10 | 36.09 |
| Support Level | $194.03 | $32.20 |
| Resistance Level | $251.09 | $33.92 |
| Average True Range (ATR) | 7.50 | 0.85 |
| MACD | 2.09 | 0.13 |
| Stochastic Oscillator | 80.56 | 23.76 |
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Based in Dallas, Copart operates an online salvage vehicle auction with operations in 11 countries across North America, Europe, and the Middle East, facilitating over 4 million transactions annually. The company utilizes its virtual bidding platform, VB3, to connect vehicle sellers with over 750,000 registered buyers around the world. Buyers primarily consist of vehicle dismantlers, rebuilders, individuals and used vehicle retailers. About 80% of Copart's vehicle volume is supplied by auto insurance companies holding vehicles deemed a total loss. Copart also offers services such as vehicle transportation, storage, title transfer, and salvage value estimation. The company primarily operates on a consignment basis and collects fees based on the vehicle's final selling price.